Foghorn Therapeutics

Price & Volume

Stats

52W Range	$2.94-$8.44
Market Cap	$261.2M
Shares Short	778,105

Financials

Revenue (12 Mos)	$24.5M
Revenue Growth (YoY)	4.4%
Gross Profit (12 Mos)	-$59.4M
Diluted EPS	-$1.14

News

Yahoo Finance • 21 days ago

Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences

Yahoo Finance • 25 days ago

Foghorn Therapeutics Announces Updates for Selective ARID1B, Selective CBP and Selective EP300 Degrader Programs

Yahoo Finance • last month

Foghorn Therapeutics Announces Significant Progress for Selective ARID1B Degrader at the 8th Annual TPD and Induced Proximity Summit

Yahoo Finance • 3 months ago

IQVIA and Flagship Pioneering Announce Strategic Collaboration to Accelerate the Development of Breakthrough Life Sciences Companies

About

CEO	Mr. Adrian H. B. Gottschalk
Address	500 Technology Square, Cambridge, MA, United States, 02139
Sector	Healthcare
Industry	Biotechnology
Full-Time Employees	112